News for 'biology'

NEET 2025: Can I Pursue MBBS After BSc?

NEET 2025: Can I Pursue MBBS After BSc?

Rediff.com12 Mar 2025

rediffGURU Dr Nagarajan JSK helps students make the right career choices, particularly in the fields of medicine and pharmacy.

'Strongest evidence' of life outside earth found

'Strongest evidence' of life outside earth found

Rediff.com17 Apr 2025

Researchers have detected hints of molecules known to be produced by marine organisms on the exoplanet K2-18 b, providing "the strongest evidence yet" of life outside the Solar System. While the discovery is exciting, more data is needed to confirm whether the molecules are indeed produced by life or through other chemical processes. The exoplanet, over 8.5 times as massive as Earth, lies 120 light-years from Earth and orbits the star 'K2-18'.

10 Medical Streams After Class 12

10 Medical Streams After Class 12

Rediff.com15 May 2025

While MBBS continues to be the most sought-after stream for medical aspirants, post pandemic, the demand for skilled nurses and physiotherapists are on the rise, notes Nayagam PP, career counsellor and founder of EduJob360.

Tariff war: RBI more worried about its impact on growth than inflation

Tariff war: RBI more worried about its impact on growth than inflation

Rediff.com9 Apr 2025

Amid the ongoing global tariff war, Reserve Bank Governor Sanjay Malhotra on Wednesday said he is more worried about its impact on growth than inflation. Speaking to the media after presentation of the first bi-monthly monetary policy for the current financial year, Malhotra said, RBI has reduced the growth forecast for 2025-26 by 20 basis points to 6.5 per cent.

'Tariffs will hurt insurance, patients and everyone'

'Tariffs will hurt insurance, patients and everyone'

Rediff.com10 Feb 2025

After registering a net profit of Rs 25.1 crore in Q3FY25 and consolidated revenues growing by 7 per cent on a like-for-like basis, Siddharth Mittal, chief executive officer (CEO) and managing director, Biocon, told Sohini Das/Business Standard in a virtual interaction that local manufacturing in the US is a trade off between cost and qualifying to do business there.

India, US trade talks likely to resume in Washington

India, US trade talks likely to resume in Washington

Rediff.com17 Apr 2025

An Indian official team is likely to visit Washington next week to iron out differences on certain issues before formally launching negotiations for the proposed India-US bilateral trade agreement (BTA), an official said. The visit, which comes within weeks of a high-level US team visiting India, indicates that the talks for the BTA are gaining momentum.

Abandoned 20 yrs ago, Spanish woman in India to find mom

Abandoned 20 yrs ago, Spanish woman in India to find mom

Rediff.com5 Jan 2025

Sneha, a Spanish citizen, has returned to India in search of her biological mother, who had abandoned her and her brother 20 years ago.

Female athletes forced into genetic test?

Female athletes forced into genetic test?

Rediff.com25 Mar 2025

Female athletes will soon have to undergo a one-time genetic test to compete in women's events, World Athletics president Sebastian Coe said on Tuesday, after proposals to tighten eligibility rules were discussed at the body's council.

'Lost 6 Years Preparing For NEET. Can I Do MBA Now?'

'Lost 6 Years Preparing For NEET. Can I Do MBA Now?'

Rediff.com7 May 2025

rediffGURU Dr Nagarajan JSK helps students make the right career choices.

Do You Want To Intern Abroad?

Do You Want To Intern Abroad?

Rediff.com6 Mar 2025

The Inlaks-Ravi Sankaran Internship for field biology, ecology and conservation is inviting applications from young applicants with bold and unconventional ideas for tackling conservation problems.

Mankind Pharma Targets Anti-Obesity Drug

Mankind Pharma Targets Anti-Obesity Drug

Rediff.com6 Mar 2025

'Obesity is a raging conversation globally now, and manufacturing of generics will pick up after the patent expires.'

SC slams NGO for opposing Jayakwadi Dam solar project

SC slams NGO for opposing Jayakwadi Dam solar project

Rediff.com2 Apr 2025

The Supreme Court of India has dismissed a petition filed by an NGO challenging the construction of a renewable energy project at the Jayakwadi Dam in Maharashtra. The court criticized the NGO for opposing the project, stating that it would be detrimental to the country's progress if every project was resisted. The court also raised questions about the NGO's bona fides and funding, suggesting that it may have been influenced by a company that lost the tender for the project. The project, a floating solar power plant, was approved by the National Green Tribunal (NGT) and the Ministry of Environment, Forests and Climate Change. The NGT had previously dismissed the NGO's plea, stating that it could not find any law prohibiting such activities in the eco-sensitive zone. The Supreme Court upheld the NGT's decision, finding no grounds to interfere.

IISER Aptitude Test Applications To Open On March 10

IISER Aptitude Test Applications To Open On March 10

Rediff.com8 Mar 2025

The IISER Aptitude Test is conducted for students who wish to get admission to IISER.

'End of war on women's sports'

'End of war on women's sports'

Rediff.com6 Feb 2025

Trump signs order banning participation of transgender athletes

'Daughter-In-Law Doesn't Want Kids. Can We Ask For Divorce?'

'Daughter-In-Law Doesn't Want Kids. Can We Ask For Divorce?'

Rediff.com14 Apr 2025

If your daughter-in-law is not prepared to be a mother, there's obviously a reason for this and this is between the couple, advises rediffGURU Anu Krishna.

Paranoid India Inc wants early conclusion of trade pact with US

Paranoid India Inc wants early conclusion of trade pact with US

Rediff.com26 Mar 2025

The Indian industry is paranoid about the USA's plan to impose reciprocal tariffs and wants early conclusion of a bilateral trade agreement, sources said on Wednesday. They said that the talks for the proposed bilateral trade agreement are going well.

US tariffs: India not in a hurry, to follow wait and watch approach

US tariffs: India not in a hurry, to follow wait and watch approach

Rediff.com3 Apr 2025

The official said there are both challenges and opportunities for India as many of its competitor countries in exports, such as China Vietnam, Bangladesh, Cambodia and Thailand, face higher duties.

The NSG Calendar Is Here!

The NSG Calendar Is Here!

Rediff.com23 Jan 2025

This year's calendar has images including night combat operations, enhanced anti-hijack operations.

5 more GBS cases found in Maharashtra, tally reaches to 163

5 more GBS cases found in Maharashtra, tally reaches to 163

Rediff.com4 Feb 2025

The number of suspected Guillain-Barre Syndrome (GBS) cases in Maharashtra has reached 163, with five deaths reported so far. Five new cases were detected in Pune, bringing the total number of confirmed cases to 127. The official also stated that 168 water samples from different parts of Pune city were sent for chemical and biological analysis, and eight water sources were found to be contaminated.

GBS Disease: 16 Patients On Ventilator

GBS Disease: 16 Patients On Ventilator

Rediff.com27 Jan 2025

Water samples from different parts of Pune have been sent to the public health laboratory for chemical and biological analysis.

AI To Design: Career Choices After Class 12

AI To Design: Career Choices After Class 12

Rediff.com17 Apr 2025

rediffGURU Radheshyam Zanwar offers guidance on the various courses students can pursue after completing Class 10 and 12.

India, US to start 3-day trade talks from Wednesday

India, US to start 3-day trade talks from Wednesday

Rediff.com25 Mar 2025

Senior officials of India and the US will begin three-day talks on the proposed bilateral trade agreement in New Delhi on Wednesday amid threats of reciprocal tariffs from the Trump-administration, an official said. To formally start the negotiations on the pact, Assistant US Trade Representative for South and Central Asia Brendan Lynch, along with a team of officials, is in New Delhi.

Covid-19: China refutes claims of 'gain-of-function' research at Wuhan lab

Covid-19: China refutes claims of 'gain-of-function' research at Wuhan lab

Rediff.com12 Feb 2025

China has firmly denied that its Wuhan Institute of Virology conducted gain-of-function studies on coronavirus, rejecting allegations that the US Agency for International Development (USAID) funded such research at the lab. The Chinese Foreign Ministry spokesperson, Guo Jiakun, emphasized that the lab has never engaged in gain-of-function research, designed, made, or leaked COVID-19. China has also reiterated its stance on the origins-tracing of COVID-19, stating that the pandemic was "extremely unlikely" to have originated from a lab leak, as concluded by the WHO-China joint mission.

Trade talks: India, US to hold wrap-up session on Sat

Trade talks: India, US to hold wrap-up session on Sat

Rediff.com28 Mar 2025

India and the visiting US officials have decided to hold a wrap-up session on Saturday morning to conclude the three-day talks on the proposed bilateral trade agreement, government sources said. They said the discussions are at a "very" early stage.

IIT Madras director defends cow urine claims, cites US journals

IIT Madras director defends cow urine claims, cites US journals

Rediff.com20 Jan 2025

IIT Madras director V Kamakoti defended his controversial statement claiming that cow urine has medicinal properties, citing scientific evidence published in US journals. He pointed to research published in 'Nature' in 2021 that identified peptides in cow urine with potential bioactivities. However, his remarks have been criticized by members of various political parties.

EXPLAINED: Trump's reciprocal tariffs

EXPLAINED: Trump's reciprocal tariffs

Rediff.com3 Apr 2025

Here is a list of Q & As to explain these issues and implications of the US move.

India, US decide to hold sector-specific talks for proposed trade pact

India, US decide to hold sector-specific talks for proposed trade pact

Rediff.com29 Mar 2025

India and the US have decided to hold sector-specific talks in the coming weeks to finalise the structure of the proposed bilateral trade agreement (BTA), the government said on Saturday. The engagement between the two countries came in the backdrop of the USA's threat to impose reciprocal tariffs on its key trading partners, including India, on April 2.

Biological E's Corbevax cleared as Covid booster dose

Biological E's Corbevax cleared as Covid booster dose

Rediff.com4 Jun 2022

BE's Corbevax is the first such vaccine in India to be approved as a heterologous COVID-19 booster in the country.

Collecting biological samples of convicts unconstitutional: Chidambaram

Collecting biological samples of convicts unconstitutional: Chidambaram

Rediff.com6 Apr 2022

The former Union home minister claimed that the provisions in the bill can be misused as the police can arrest and take fingerprints and DNA samples of even those who are taking part in political rallies.

ALERT! New coronavirus found in China's Wuhan

ALERT! New coronavirus found in China's Wuhan

Rediff.com22 Feb 2025

A Chinese team of virologists has discovered a new bat coronavirus that can infect human cells, raising concerns about potential animal-to-human transmission. The virus, a new lineage of the HKU5 coronavirus, uses the same human receptor as the virus that causes COVID-19. The study, led by Shi Zhengli, a prominent virologist at the Wuhan Institute of Virology, was published in the journal Cell. The discovery comes amid ongoing scrutiny of the Wuhan lab, which was previously accused of being the source of the COVID-19 pandemic. The Chinese government has denied any involvement in the virus's origin and insists that the Wuhan lab never engaged in gain-of-function studies on coronaviruses.

Oops! Ab Kya? Review: A Matter Of Excess

Oops! Ab Kya? Review: A Matter Of Excess

Rediff.com21 Feb 2025

There is much in Oops! Ab Kya? that continues to linger till the cliff-hanger in the final episode. And yet, there's a great deal about the show that doesn't quite come together, observes Mayur Sanap.

Biocon Biologics Plan Molecule Launch Every 1-2 Years

Biocon Biologics Plan Molecule Launch Every 1-2 Years

Rediff.com17 Aug 2022

'The tie-up with Serum Institute Life Sciences brings to the table their strengths in manufacturing and also their vaccine portfolio.'

As pure 'as alkaline water': UP quotes scientist on Sangam water

As pure 'as alkaline water': UP quotes scientist on Sangam water

Rediff.com21 Feb 2025

The Uttar Pradesh government, citing a scientist, has asserted that Ganga water at the ongoing Maha Kumbh in Prayagraj is as pure as "alkaline water", debunking concerns raised by the Central Pollution Control Board (CPCB) about water quality. The government claims that a scientist found no bacterial growth or decline in the water's pH level, despite millions of devotees bathing in the river. However, experts caution that the quality of the Ganga water is not static and can vary greatly depending on various factors.

Sangam water unfit for bathing, contains faecal bacteria: Govt data

Sangam water unfit for bathing, contains faecal bacteria: Govt data

Rediff.com19 Feb 2025

The Ganga water at the Triveni Sangam in Prayagraj, where lakhs of people are taking a holy dip every day during the ongoing Maha Kumbh, is currently unsafe for bathing as it exceeds the prescribed limit for biological oxygen demand (BOD), a key parameter to determine water quality, according to government data.

Why Kerala Opposes Sand Sea Mining

Why Kerala Opposes Sand Sea Mining

Rediff.com19 Apr 2025

If as critics point out, the environmental impact assessment study was commissioned only after the auction process got underway with not all the stakeholders getting to know of it, then the government has already compromised the trust it could have enjoyed with Kerala's public including its coastal communities, points out Shyam G Menon.

India hopes for temporary tariff waiver as US official comes calling

India hopes for temporary tariff waiver as US official comes calling

Rediff.com24 Mar 2025

India and the United States will finalize the contours, schedule of negotiations, and terms of reference for a proposed bilateral trade agreement (BTA) during a three-day meeting beginning Tuesday. The agreement is expected to be finalized in two tranches, with the first phase focusing on goods trade. The US team, led by Assistant US Trade Representative for South and Central Asia Brendan Lynch, will be in India from March 25-29 to discuss the agreement. Both countries are aiming to conclude the first phase of the agreement by fall 2025.

In a 1st, Indian university grows spinach tissue in space

In a 1st, Indian university grows spinach tissue in space

Rediff.com13 Jan 2025

The spinach callus tissue, sent by Amity University-Mumbai to space, has shown signs of growth in the POEM-4 module that is orbiting the earth at an altitude of 350 kms, scientists associated with the experiment said.

Why Aamir Got Married At 21

Why Aamir Got Married At 21

Rediff.com14 Mar 2025

'Reena stayed in the next building. We fell in love but had to meet secretly because her parents didn't approve of me.' 'I would always be afraid that her parents would get her married off to somebody else.'

Upper-teens EPS growth likely for Gland Pharma in next two financial yrs

Upper-teens EPS growth likely for Gland Pharma in next two financial yrs

Rediff.com13 Nov 2024

Gland Pharma beat muted expectations for Q2FY25. There was increased Ebitda (Earnings before interest, taxes, depreciation and amortisation) loss at Cenexi, the CRAM subsidiary. However, overall Ebitda margin was better than expectations at 21.1 per cent. But given two years of earnings decline in FY23 and FY24, the business may have bottomed and upper-teens EPS (earnings per share) growth looks possible over next two financial years.

Maharashtra, Bengal report suspected GBS deaths

Maharashtra, Bengal report suspected GBS deaths

Rediff.com30 Jan 2025

A woman is suspected to have died of Guillain-Barr syndrome (GBS) in Maharashtra on Wednesday, while 16 new cases of the rare nerve disorder were reported in the state, health officials said.